nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—SLC22A2—Cytarabine—lymphatic system cancer	0.141	0.18	CbGbCtD
Quinine—SLC22A1—Cytarabine—lymphatic system cancer	0.123	0.156	CbGbCtD
Quinine—CYP1A2—Carmustine—lymphatic system cancer	0.0629	0.0803	CbGbCtD
Quinine—CYP3A5—Teniposide—lymphatic system cancer	0.0568	0.0725	CbGbCtD
Quinine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0511	0.0653	CbGbCtD
Quinine—CYP2C19—Teniposide—lymphatic system cancer	0.0458	0.0585	CbGbCtD
Quinine—SLCO1A2—Methotrexate—lymphatic system cancer	0.0399	0.0509	CbGbCtD
Quinine—CYP2C9—Teniposide—lymphatic system cancer	0.0381	0.0486	CbGbCtD
Quinine—CYP3A7—Vincristine—lymphatic system cancer	0.0365	0.0465	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0365	0.0465	CbGbCtD
Quinine—CYP3A5—Vincristine—lymphatic system cancer	0.0273	0.0349	CbGbCtD
Quinine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0259	0.033	CbGbCtD
Quinine—CYP3A4—Cytarabine—lymphatic system cancer	0.0225	0.0287	CbGbCtD
Quinine—CYP3A4—Teniposide—lymphatic system cancer	0.0222	0.0283	CbGbCtD
Quinine—ABCB1—Vincristine—lymphatic system cancer	0.0178	0.0227	CbGbCtD
Quinine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0155	0.0198	CbGbCtD
Quinine—ABCB1—Methotrexate—lymphatic system cancer	0.0108	0.0137	CbGbCtD
Quinine—CYP3A4—Vincristine—lymphatic system cancer	0.0107	0.0136	CbGbCtD
Quinine—Confusional state—Fludarabine—lymphatic system cancer	0.000584	0.0027	CcSEcCtD
Quinine—Neutropenia—Vincristine—lymphatic system cancer	0.000582	0.00269	CcSEcCtD
Quinine—Oedema—Fludarabine—lymphatic system cancer	0.000579	0.00268	CcSEcCtD
Quinine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000575	0.00266	CcSEcCtD
Quinine—Decreased appetite—Teniposide—lymphatic system cancer	0.000573	0.00265	CcSEcCtD
Quinine—Renal failure—Carmustine—lymphatic system cancer	0.000571	0.00264	CcSEcCtD
Quinine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000568	0.00263	CcSEcCtD
Quinine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000568	0.00262	CcSEcCtD
Quinine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000568	0.00262	CcSEcCtD
Quinine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000567	0.00262	CcSEcCtD
Quinine—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000566	0.00262	CcSEcCtD
Quinine—Rash—Mechlorethamine—lymphatic system cancer	0.000563	0.0026	CcSEcCtD
Quinine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000563	0.0026	CcSEcCtD
Quinine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00056	0.00259	CcSEcCtD
Quinine—Flushing—Bleomycin—lymphatic system cancer	0.000554	0.00256	CcSEcCtD
Quinine—Anorexia—Fludarabine—lymphatic system cancer	0.000552	0.00255	CcSEcCtD
Quinine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000543	0.00251	CcSEcCtD
Quinine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000539	0.00249	CcSEcCtD
Quinine—Chills—Bleomycin—lymphatic system cancer	0.000536	0.00248	CcSEcCtD
Quinine—Bone disorder—Methotrexate—lymphatic system cancer	0.000532	0.00246	CcSEcCtD
Quinine—Sweating—Vincristine—lymphatic system cancer	0.000532	0.00246	CcSEcCtD
Quinine—Renal failure—Mitoxantrone—lymphatic system cancer	0.000531	0.00245	CcSEcCtD
Quinine—Nausea—Mechlorethamine—lymphatic system cancer	0.000531	0.00245	CcSEcCtD
Quinine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000527	0.00244	CcSEcCtD
Quinine—Jaundice—Mitoxantrone—lymphatic system cancer	0.000526	0.00243	CcSEcCtD
Quinine—Haemoglobin—Carmustine—lymphatic system cancer	0.000524	0.00242	CcSEcCtD
Quinine—Urticaria—Teniposide—lymphatic system cancer	0.000523	0.00242	CcSEcCtD
Quinine—Oliguria—Methotrexate—lymphatic system cancer	0.000522	0.00241	CcSEcCtD
Quinine—Haemorrhage—Carmustine—lymphatic system cancer	0.000521	0.00241	CcSEcCtD
Quinine—Abdominal pain—Teniposide—lymphatic system cancer	0.000521	0.00241	CcSEcCtD
Quinine—Body temperature increased—Teniposide—lymphatic system cancer	0.000521	0.00241	CcSEcCtD
Quinine—Erythema—Bleomycin—lymphatic system cancer	0.00052	0.0024	CcSEcCtD
Quinine—Sweating—Mitoxantrone—lymphatic system cancer	0.000518	0.00239	CcSEcCtD
Quinine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000516	0.00239	CcSEcCtD
Quinine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000504	0.00233	CcSEcCtD
Quinine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000503	0.00233	CcSEcCtD
Quinine—Visual impairment—Carmustine—lymphatic system cancer	0.000503	0.00232	CcSEcCtD
Quinine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0005	0.00231	CcSEcCtD
Quinine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000494	0.00228	CcSEcCtD
Quinine—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000492	0.00227	CcSEcCtD
Quinine—Urethral disorder—Vincristine—lymphatic system cancer	0.000488	0.00226	CcSEcCtD
Quinine—Eye disorder—Carmustine—lymphatic system cancer	0.000487	0.00225	CcSEcCtD
Quinine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000487	0.00225	CcSEcCtD
Quinine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000485	0.00224	CcSEcCtD
Quinine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000485	0.00224	CcSEcCtD
Quinine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000485	0.00224	CcSEcCtD
Quinine—Flushing—Carmustine—lymphatic system cancer	0.000484	0.00224	CcSEcCtD
Quinine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000477	0.0022	CcSEcCtD
Quinine—Asthenia—Teniposide—lymphatic system cancer	0.000473	0.00218	CcSEcCtD
Quinine—Pruritus—Teniposide—lymphatic system cancer	0.000466	0.00215	CcSEcCtD
Quinine—Leukopenia—Bleomycin—lymphatic system cancer	0.000465	0.00215	CcSEcCtD
Quinine—Cardiac disorder—Vincristine—lymphatic system cancer	0.000462	0.00214	CcSEcCtD
Quinine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000458	0.00211	CcSEcCtD
Quinine—Mental disorder—Carmustine—lymphatic system cancer	0.000457	0.00211	CcSEcCtD
Quinine—Erythema—Carmustine—lymphatic system cancer	0.000454	0.0021	CcSEcCtD
Quinine—Malnutrition—Carmustine—lymphatic system cancer	0.000454	0.0021	CcSEcCtD
Quinine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000452	0.00209	CcSEcCtD
Quinine—Diarrhoea—Teniposide—lymphatic system cancer	0.000451	0.00208	CcSEcCtD
Quinine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000449	0.00207	CcSEcCtD
Quinine—Chest pain—Bleomycin—lymphatic system cancer	0.000443	0.00205	CcSEcCtD
Quinine—Myalgia—Bleomycin—lymphatic system cancer	0.000443	0.00205	CcSEcCtD
Quinine—Coma—Methotrexate—lymphatic system cancer	0.000439	0.00203	CcSEcCtD
Quinine—Mental disorder—Vincristine—lymphatic system cancer	0.000436	0.00202	CcSEcCtD
Quinine—Chills—Mitoxantrone—lymphatic system cancer	0.000435	0.00201	CcSEcCtD
Quinine—Ecchymosis—Methotrexate—lymphatic system cancer	0.000435	0.00201	CcSEcCtD
Quinine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000428	0.00198	CcSEcCtD
Quinine—Confusional state—Bleomycin—lymphatic system cancer	0.000428	0.00198	CcSEcCtD
Quinine—Vision blurred—Carmustine—lymphatic system cancer	0.000428	0.00198	CcSEcCtD
Quinine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000426	0.00197	CcSEcCtD
Quinine—Tremor—Carmustine—lymphatic system cancer	0.000425	0.00197	CcSEcCtD
Quinine—Oedema—Bleomycin—lymphatic system cancer	0.000424	0.00196	CcSEcCtD
Quinine—Erythema—Mitoxantrone—lymphatic system cancer	0.000422	0.00195	CcSEcCtD
Quinine—Vomiting—Teniposide—lymphatic system cancer	0.000419	0.00194	CcSEcCtD
Quinine—Agitation—Carmustine—lymphatic system cancer	0.000417	0.00193	CcSEcCtD
Quinine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000416	0.00192	CcSEcCtD
Quinine—Asthenia—Fludarabine—lymphatic system cancer	0.000415	0.00192	CcSEcCtD
Quinine—Rash—Teniposide—lymphatic system cancer	0.000415	0.00192	CcSEcCtD
Quinine—Dermatitis—Teniposide—lymphatic system cancer	0.000415	0.00192	CcSEcCtD
Quinine—Headache—Teniposide—lymphatic system cancer	0.000413	0.00191	CcSEcCtD
Quinine—Pruritus—Fludarabine—lymphatic system cancer	0.00041	0.00189	CcSEcCtD
Quinine—Leukopenia—Carmustine—lymphatic system cancer	0.000406	0.00188	CcSEcCtD
Quinine—Anorexia—Bleomycin—lymphatic system cancer	0.000405	0.00187	CcSEcCtD
Quinine—Agitation—Vincristine—lymphatic system cancer	0.000398	0.00184	CcSEcCtD
Quinine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000398	0.00184	CcSEcCtD
Quinine—Photosensitivity—Methotrexate—lymphatic system cancer	0.000398	0.00184	CcSEcCtD
Quinine—Hypotension—Bleomycin—lymphatic system cancer	0.000397	0.00183	CcSEcCtD
Quinine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000396	0.00183	CcSEcCtD
Quinine—Convulsion—Carmustine—lymphatic system cancer	0.000393	0.00182	CcSEcCtD
Quinine—Nausea—Teniposide—lymphatic system cancer	0.000391	0.00181	CcSEcCtD
Quinine—Vertigo—Vincristine—lymphatic system cancer	0.000389	0.0018	CcSEcCtD
Quinine—Leukopenia—Vincristine—lymphatic system cancer	0.000388	0.00179	CcSEcCtD
Quinine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000387	0.00179	CcSEcCtD
Quinine—Myalgia—Carmustine—lymphatic system cancer	0.000386	0.00179	CcSEcCtD
Quinine—Chest pain—Carmustine—lymphatic system cancer	0.000386	0.00179	CcSEcCtD
Quinine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000378	0.00175	CcSEcCtD
Quinine—Renal failure acute—Methotrexate—lymphatic system cancer	0.000378	0.00175	CcSEcCtD
Quinine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000378	0.00175	CcSEcCtD
Quinine—Convulsion—Vincristine—lymphatic system cancer	0.000375	0.00174	CcSEcCtD
Quinine—Confusional state—Carmustine—lymphatic system cancer	0.000374	0.00173	CcSEcCtD
Quinine—Oedema—Carmustine—lymphatic system cancer	0.00037	0.00171	CcSEcCtD
Quinine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00037	0.00171	CcSEcCtD
Quinine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000369	0.00171	CcSEcCtD
Quinine—Myalgia—Vincristine—lymphatic system cancer	0.000369	0.00171	CcSEcCtD
Quinine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000368	0.0017	CcSEcCtD
Quinine—Vomiting—Fludarabine—lymphatic system cancer	0.000368	0.0017	CcSEcCtD
Quinine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000366	0.00169	CcSEcCtD
Quinine—Rash—Fludarabine—lymphatic system cancer	0.000365	0.00169	CcSEcCtD
Quinine—Dermatitis—Fludarabine—lymphatic system cancer	0.000365	0.00169	CcSEcCtD
Quinine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000363	0.00168	CcSEcCtD
Quinine—Headache—Fludarabine—lymphatic system cancer	0.000363	0.00168	CcSEcCtD
Quinine—Tachycardia—Carmustine—lymphatic system cancer	0.000362	0.00167	CcSEcCtD
Quinine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000359	0.00166	CcSEcCtD
Quinine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000359	0.00166	CcSEcCtD
Quinine—Oedema—Vincristine—lymphatic system cancer	0.000354	0.00163	CcSEcCtD
Quinine—Anorexia—Carmustine—lymphatic system cancer	0.000353	0.00163	CcSEcCtD
Quinine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00035	0.00162	CcSEcCtD
Quinine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000347	0.00161	CcSEcCtD
Quinine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000347	0.0016	CcSEcCtD
Quinine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000346	0.0016	CcSEcCtD
Quinine—Hypotension—Carmustine—lymphatic system cancer	0.000346	0.0016	CcSEcCtD
Quinine—Oedema—Mitoxantrone—lymphatic system cancer	0.000344	0.00159	CcSEcCtD
Quinine—Nausea—Fludarabine—lymphatic system cancer	0.000344	0.00159	CcSEcCtD
Quinine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000342	0.00158	CcSEcCtD
Quinine—Shock—Mitoxantrone—lymphatic system cancer	0.000339	0.00157	CcSEcCtD
Quinine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000338	0.00156	CcSEcCtD
Quinine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000337	0.00156	CcSEcCtD
Quinine—Urticaria—Bleomycin—lymphatic system cancer	0.000337	0.00156	CcSEcCtD
Quinine—Anorexia—Vincristine—lymphatic system cancer	0.000337	0.00156	CcSEcCtD
Quinine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000336	0.00155	CcSEcCtD
Quinine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000336	0.00155	CcSEcCtD
Quinine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000335	0.00155	CcSEcCtD
Quinine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000333	0.00154	CcSEcCtD
Quinine—Hypotension—Vincristine—lymphatic system cancer	0.00033	0.00153	CcSEcCtD
Quinine—Dyspnoea—Carmustine—lymphatic system cancer	0.00033	0.00153	CcSEcCtD
Quinine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000328	0.00152	CcSEcCtD
Quinine—Ataxia—Methotrexate—lymphatic system cancer	0.000328	0.00152	CcSEcCtD
Quinine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000322	0.00149	CcSEcCtD
Quinine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000322	0.00149	CcSEcCtD
Quinine—Decreased appetite—Carmustine—lymphatic system cancer	0.000322	0.00149	CcSEcCtD
Quinine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000322	0.00149	CcSEcCtD
Quinine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00032	0.00148	CcSEcCtD
Quinine—Breast disorder—Methotrexate—lymphatic system cancer	0.000315	0.00146	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000314	0.00145	CcSEcCtD
Quinine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000314	0.00145	CcSEcCtD
Quinine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000313	0.00145	CcSEcCtD
Quinine—Decreased appetite—Vincristine—lymphatic system cancer	0.000307	0.00142	CcSEcCtD
Quinine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000307	0.00142	CcSEcCtD
Quinine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000305	0.00141	CcSEcCtD
Quinine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000305	0.00141	CcSEcCtD
Quinine—Asthenia—Bleomycin—lymphatic system cancer	0.000305	0.00141	CcSEcCtD
Quinine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000303	0.0014	CcSEcCtD
Quinine—Asthma—Methotrexate—lymphatic system cancer	0.000302	0.00139	CcSEcCtD
Quinine—Pruritus—Bleomycin—lymphatic system cancer	0.0003	0.00139	CcSEcCtD
Quinine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000299	0.00138	CcSEcCtD
Quinine—Abdominal pain—Carmustine—lymphatic system cancer	0.000293	0.00135	CcSEcCtD
Quinine—Body temperature increased—Carmustine—lymphatic system cancer	0.000293	0.00135	CcSEcCtD
Quinine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000289	0.00134	CcSEcCtD
Quinine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000287	0.00132	CcSEcCtD
Quinine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000284	0.00131	CcSEcCtD
Quinine—Neutropenia—Methotrexate—lymphatic system cancer	0.000282	0.0013	CcSEcCtD
Quinine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000282	0.0013	CcSEcCtD
Quinine—Body temperature increased—Vincristine—lymphatic system cancer	0.00028	0.00129	CcSEcCtD
Quinine—Abdominal pain—Vincristine—lymphatic system cancer	0.00028	0.00129	CcSEcCtD
Quinine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000275	0.00127	CcSEcCtD
Quinine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000274	0.00126	CcSEcCtD
Quinine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000273	0.00126	CcSEcCtD
Quinine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000272	0.00126	CcSEcCtD
Quinine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000272	0.00126	CcSEcCtD
Quinine—Vomiting—Bleomycin—lymphatic system cancer	0.00027	0.00125	CcSEcCtD
Quinine—Rash—Bleomycin—lymphatic system cancer	0.000268	0.00124	CcSEcCtD
Quinine—Dermatitis—Bleomycin—lymphatic system cancer	0.000267	0.00124	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000267	0.00123	CcSEcCtD
Quinine—Asthenia—Carmustine—lymphatic system cancer	0.000266	0.00123	CcSEcCtD
Quinine—Renal failure—Methotrexate—lymphatic system cancer	0.000264	0.00122	CcSEcCtD
Quinine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000261	0.0012	CcSEcCtD
Quinine—Sweating—Methotrexate—lymphatic system cancer	0.000258	0.00119	CcSEcCtD
Quinine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000254	0.00117	CcSEcCtD
Quinine—Asthenia—Vincristine—lymphatic system cancer	0.000254	0.00117	CcSEcCtD
Quinine—Diarrhoea—Carmustine—lymphatic system cancer	0.000253	0.00117	CcSEcCtD
Quinine—Nausea—Bleomycin—lymphatic system cancer	0.000252	0.00117	CcSEcCtD
Quinine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000251	0.00116	CcSEcCtD
Quinine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000247	0.00114	CcSEcCtD
Quinine—Dizziness—Carmustine—lymphatic system cancer	0.000245	0.00113	CcSEcCtD
Quinine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000243	0.00112	CcSEcCtD
Quinine—Diarrhoea—Vincristine—lymphatic system cancer	0.000242	0.00112	CcSEcCtD
Quinine—Hepatitis—Methotrexate—lymphatic system cancer	0.000242	0.00112	CcSEcCtD
Quinine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000242	0.00112	CcSEcCtD
Quinine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000239	0.0011	CcSEcCtD
Quinine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000237	0.00109	CcSEcCtD
Quinine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000236	0.00109	CcSEcCtD
Quinine—Vomiting—Carmustine—lymphatic system cancer	0.000236	0.00109	CcSEcCtD
Quinine—Dizziness—Vincristine—lymphatic system cancer	0.000234	0.00108	CcSEcCtD
Quinine—Rash—Carmustine—lymphatic system cancer	0.000234	0.00108	CcSEcCtD
Quinine—Dermatitis—Carmustine—lymphatic system cancer	0.000233	0.00108	CcSEcCtD
Quinine—Visual impairment—Methotrexate—lymphatic system cancer	0.000233	0.00108	CcSEcCtD
Quinine—Headache—Carmustine—lymphatic system cancer	0.000232	0.00107	CcSEcCtD
Quinine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000228	0.00106	CcSEcCtD
Quinine—Eye disorder—Methotrexate—lymphatic system cancer	0.000226	0.00104	CcSEcCtD
Quinine—Tinnitus—Methotrexate—lymphatic system cancer	0.000225	0.00104	CcSEcCtD
Quinine—Vomiting—Vincristine—lymphatic system cancer	0.000225	0.00104	CcSEcCtD
Quinine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000224	0.00104	CcSEcCtD
Quinine—Rash—Vincristine—lymphatic system cancer	0.000223	0.00103	CcSEcCtD
Quinine—Dermatitis—Vincristine—lymphatic system cancer	0.000223	0.00103	CcSEcCtD
Quinine—Headache—Vincristine—lymphatic system cancer	0.000222	0.00102	CcSEcCtD
Quinine—Nausea—Carmustine—lymphatic system cancer	0.00022	0.00102	CcSEcCtD
Quinine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000219	0.00101	CcSEcCtD
Quinine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000218	0.00101	CcSEcCtD
Quinine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000218	0.00101	CcSEcCtD
Quinine—Rash—Mitoxantrone—lymphatic system cancer	0.000217	0.001	CcSEcCtD
Quinine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000217	0.001	CcSEcCtD
Quinine—Chills—Methotrexate—lymphatic system cancer	0.000217	0.001	CcSEcCtD
Quinine—Headache—Mitoxantrone—lymphatic system cancer	0.000216	0.000997	CcSEcCtD
Quinine—Mental disorder—Methotrexate—lymphatic system cancer	0.000212	0.000978	CcSEcCtD
Quinine—Malnutrition—Methotrexate—lymphatic system cancer	0.00021	0.000972	CcSEcCtD
Quinine—Erythema—Methotrexate—lymphatic system cancer	0.00021	0.000972	CcSEcCtD
Quinine—Nausea—Vincristine—lymphatic system cancer	0.00021	0.000971	CcSEcCtD
Quinine—Nausea—Mitoxantrone—lymphatic system cancer	0.000205	0.000946	CcSEcCtD
Quinine—Vision blurred—Methotrexate—lymphatic system cancer	0.000198	0.000916	CcSEcCtD
Quinine—Vertigo—Methotrexate—lymphatic system cancer	0.000189	0.000873	CcSEcCtD
Quinine—Leukopenia—Methotrexate—lymphatic system cancer	0.000188	0.00087	CcSEcCtD
Quinine—Convulsion—Methotrexate—lymphatic system cancer	0.000182	0.000842	CcSEcCtD
Quinine—Chest pain—Methotrexate—lymphatic system cancer	0.000179	0.000827	CcSEcCtD
Quinine—Myalgia—Methotrexate—lymphatic system cancer	0.000179	0.000827	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000178	0.000822	CcSEcCtD
Quinine—Confusional state—Methotrexate—lymphatic system cancer	0.000173	0.0008	CcSEcCtD
Quinine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000168	0.000778	CcSEcCtD
Quinine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000168	0.000777	CcSEcCtD
Quinine—Skin disorder—Methotrexate—lymphatic system cancer	0.000167	0.00077	CcSEcCtD
Quinine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000166	0.000767	CcSEcCtD
Quinine—Anorexia—Methotrexate—lymphatic system cancer	0.000164	0.000756	CcSEcCtD
Quinine—Hypotension—Methotrexate—lymphatic system cancer	0.00016	0.000741	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000156	0.000723	CcSEcCtD
Quinine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000153	0.000707	CcSEcCtD
Quinine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000149	0.000689	CcSEcCtD
Quinine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000148	0.000685	CcSEcCtD
Quinine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000141	0.000654	CcSEcCtD
Quinine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00014	0.000649	CcSEcCtD
Quinine—Urticaria—Methotrexate—lymphatic system cancer	0.000136	0.00063	CcSEcCtD
Quinine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000136	0.000627	CcSEcCtD
Quinine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000136	0.000627	CcSEcCtD
Quinine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000126	0.000584	CcSEcCtD
Quinine—Asthenia—Methotrexate—lymphatic system cancer	0.000123	0.000569	CcSEcCtD
Quinine—Pruritus—Methotrexate—lymphatic system cancer	0.000121	0.000561	CcSEcCtD
Quinine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000117	0.000543	CcSEcCtD
Quinine—Dizziness—Methotrexate—lymphatic system cancer	0.000113	0.000524	CcSEcCtD
Quinine—Vomiting—Methotrexate—lymphatic system cancer	0.000109	0.000504	CcSEcCtD
Quinine—Rash—Methotrexate—lymphatic system cancer	0.000108	0.0005	CcSEcCtD
Quinine—Dermatitis—Methotrexate—lymphatic system cancer	0.000108	0.0005	CcSEcCtD
Quinine—Headache—Methotrexate—lymphatic system cancer	0.000107	0.000497	CcSEcCtD
Quinine—Nausea—Methotrexate—lymphatic system cancer	0.000102	0.000471	CcSEcCtD
